Literature DB >> 10232868

Abdominal symptoms are not related to anorectal function in the irritable bowel syndrome.

G Ragnarsson1, O Hallböök, G Bodemar.   

Abstract

BACKGROUND: The pathophysiologic significance of altered intestinal motility and perception in irritable bowel syndrome (IBS) is unclear, as a consistent association with abdominal symptoms has not been proved. Our aim was to investigate the association between abdominal symptoms and anorectal function in IBS.
METHODS: Fifty-two patients recorded their symptoms daily for I week. At the end of the week anorectal function was investigated by manovolumetry before and after a standardized fatty meal. Cluster analysis of daily recorded symptoms and both pre- and postprandial manovolumetric data was performed to identify symptom and physiologic subgroups.
RESULTS: Symptom subgroups did not differ with regard to anorectal function. Physiologic subgroups did not differ with regard to daily recorded symptoms. Postprandially, the thresholds eliciting maximal tolerable distention were decreased in 22 of the patients. This increase in rectal sensitivity was not related to symptoms and may have been caused by the preprandial anorectal measurement, since thresholds for maximal tolerable distention decreased significantly in nine patients retested without an intervening meal.
CONCLUSIONS: Abdominal symptoms and anorectal function are not related in IBS.

Entities:  

Mesh:

Year:  1999        PMID: 10232868     DOI: 10.1080/00365529950173645

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Increased beta-adrenergic sensitivity correlates with visceral hypersensitivity in patients with constipation-predominant irritable bowel syndrome.

Authors:  Jung Ho Park; Poong-Lyul Rhee; Hyun Seo Kim; Jun Haeng Lee; Young-Ho Kim; Jae Jun Kim; Jong Chul Rhee; Eun Ho Kang; Bum-Hee Yu
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

2.  Sex specific alterations in autonomic function among patients with irritable bowel syndrome.

Authors:  K Tillisch; E A Mayer; J S Labus; J Stains; L Chang; B D Naliboff
Journal:  Gut       Date:  2005-05-28       Impact factor: 23.059

3.  Anorectal function and dyssynergic defecation in different subgroups of patients with irritable bowel syndrome.

Authors:  Agata Mulak; Leszek Paradowski
Journal:  Int J Colorectal Dis       Date:  2010-04-22       Impact factor: 2.571

4.  Meta-analysis: do irritable bowel syndrome symptoms vary between men and women?

Authors:  M A Adeyemo; B M R Spiegel; L Chang
Journal:  Aliment Pharmacol Ther       Date:  2010-07-22       Impact factor: 8.171

5.  Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome.

Authors:  Tisha N Lunsford; Lucinda A Harris
Journal:  Int J Womens Health       Date:  2010-10-27

6.  Rectal hypersensitivity reduced by acupoint TENS in patients with diarrhea-predominant irritable bowel syndrome: a pilot study.

Authors:  Wen-Bin Xiao; Yu-Lan Liu
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

7.  Gender differences in gastrointestinal, psychological, and somatic symptoms in irritable bowel syndrome.

Authors:  Kevin C Cain; Monica E Jarrett; Robert L Burr; Sheldon Rosen; Vicky L Hertig; Margaret M Heitkemper
Journal:  Dig Dis Sci       Date:  2008-11-01       Impact factor: 3.199

Review 8.  Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones.

Authors:  Mathieu Meleine; Julien Matricon
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

9.  Rectal Mechano-sensory Function in Patients with Carcinoid Diarrhea.

Authors:  Tine Gregersen; Christina Brock; Anne-Mette Haase; Søren Laurberg; Asbjørn M Drewes; Henning Grønbæk; Klaus Krogh
Journal:  J Neurogastroenterol Motil       Date:  2016-04-30       Impact factor: 4.924

Review 10.  Sex-Gender Differences in Irritable Bowel Syndrome.

Authors:  Young Sun Kim; Nayoung Kim
Journal:  J Neurogastroenterol Motil       Date:  2018-10-01       Impact factor: 4.924

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.